Developing Health, Developing Profits
Friday, May 1, 2009
Pfizer’s Dr Ponni Subbiah is at the forefront of a revolution in the way the pharma industry views its business, who it believes its customers are, and how it can be socially responsible.
There is currently much talk of pharma’s emerging markets – China, India, Brazil, Russia – but this expanded world view still excludes most countries, and billions of the world’s population.
The most potent symbol of global poverty – and dire health needs that go with it – is sub-Saharan Africa. The pharma industry has traditionally seen its role in this region and others like it as social responsibility rather than commercial activity.
